Form 8.3 - [Abbvie. Inc]
April 28 2020 - 10:07AM
Dow Jones News
TIDM0QCV TIDM0Y7T
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING
1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) State Street Global Advisors &
Affiliates
--------------------------------------------- -------------------------------
Company dealt in AbbVie Inc.
--------------------------------------------- -------------------------------
Class of relevant security to which US$0.01 common stock
the dealings being disclosed relate (Note 2)
--------------------------------------------- -------------------------------
Date of dealing 27(th) April 2020
--------------------------------------------- -------------------------------
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of
relevant security dealt in (Note 3)
Long Short
------------------------------------- -------------------- -----------
Number (%) Number (%)
------------------------------------- ---------- -------- ------ ---
(1) Relevant securities 69,965,244 4.73785%
------------------------------------- ---------- -------- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------- ---------- -------- ------ ---
(3) Options and agreements to
purchase/sell N/A
------------------------------------- ---------- -------- ------ ---
Total 69,965,244 4.73785%
------------------------------------- ---------- -------- ------ ---
(b) Interests and short positions in relevant securities of the company,
other than the class dealt in (Note 3)
Class of relevant security: Long Short
------------------------------------------- ----------- -----------
Number (%) Number (%)
------------------------------------------- ------ --- ------ ---
(1) Relevant securities N/A
------------------------------------------- ------ --- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------------- ------ --- ------ ---
(3) Options and agreements to purchase/sell N/A
------------------------------------------- ------ --- ------ ---
Total N/A
------------------------------------------- ------ --- ------ ---
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit (Note 5)
-------------- ----------------------------- -----------------------
Purchase 4,500 84.69
-------------- ----------------------------- -----------------------
Purchase 77 84.33
-------------- ----------------------------- -----------------------
Purchase 4,665 84.14
-------------- ----------------------------- -----------------------
Purchase 300 84.03
-------------- ----------------------------- -----------------------
Purchase 100 84.69
-------------- ----------------------------- -----------------------
Purchase 200 84.69
-------------- ----------------------------- -----------------------
Purchase 97,790 84.69
-------------- ----------------------------- -----------------------
Purchase 35,560 84.69
-------------- ----------------------------- -----------------------
Purchase 43,758 84.69
-------------- ----------------------------- -----------------------
Purchase 23,868 84.69
-------------- ----------------------------- -----------------------
Purchase 11,925 84.69
-------------- ----------------------------- -----------------------
Purchase 5,000 84.15
-------------- ----------------------------- -----------------------
Purchase 400 84.03
-------------- ----------------------------- -----------------------
Purchase 564 84.69
-------------- ----------------------------- -----------------------
Purchase 127 84.48
-------------- ----------------------------- -----------------------
Purchase 2,528 84.15
-------------- ----------------------------- -----------------------
Sale 729 84.69
-------------- ----------------------------- -----------------------
Sale 191 84.39
-------------- ----------------------------- -----------------------
Sale 400 84.69
-------------- ----------------------------- -----------------------
Sale 1,700 84.69
-------------- ----------------------------- -----------------------
Sale 15,300 84.69
-------------- ----------------------------- -----------------------
Sale 200 84.69
-------------- ----------------------------- -----------------------
Sale 1,432 84.39
-------------- ----------------------------- -----------------------
Sale 812 84.69
-------------- ----------------------------- -----------------------
Sale 1,255 84.69
-------------- ----------------------------- -----------------------
Sale 1,530 84.69
-------------- ----------------------------- -----------------------
Sale 99 84.39
-------------- ----------------------------- -----------------------
Sale 1,068 84.69
-------------- ----------------------------- -----------------------
Sale 401 84.39
-------------- ----------------------------- -----------------------
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
------------- --------------------- ----------------------------- --------------
N/A
------------- --------------------- ----------------------------- --------------
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, Number of Exercise Type, e.g. Expiry Option money
e.g. call option purchasing securities to which price American, date paid/received
varying etc. the option relates European etc. per unit (Note 5)
(Note 7)
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
N/A
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
(ii) Exercising
Product name, Number of securities Exercise price per
e.g. call option unit (Note 5)
----------------- -------------------- ------------------
N/A
----------------- -------------------- ------------------
(d) Other dealings (including transactions in respect of new securities)
(Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
--------------------- ------- -------------------------
N/A
--------------------- ------- -------------------------
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or
derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person
relating to the voting rights of any relevant securities
under any option referred to on this form or relating
to the voting rights or future acquisition or disposal
of any relevant securities to which any derivative
referred to on this form is referenced. If none, this
should be stated.
-----------------------------------------------------------
N/A
-----------------------------------------------------------
Is a Supplemental Form 8 attached? (Note 9) NO
------------------------------------------------------- -----------------
Date of disclosure 28(th) April 2020
------------------------------------------------------- -----------------
Contact name Lionel Colaco
------------------------------------------------------- -----------------
Telephone number 020 33956098
------------------------------------------------------- -----------------
If a connected EFM, name of offeree/offeror with which N/A
connected
------------------------------------------------------- -----------------
If a connected EFM, state nature of connection (Note N/A
10)
------------------------------------------------------- -----------------
(END) Dow Jones Newswires
April 28, 2020 09:52 ET (13:52 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Allergan (NYSE:AGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Allergan (NYSE:AGN)
Historical Stock Chart
From Apr 2023 to Apr 2024
